Rat hepatic CYP1A1 and CYP1A2 induction by menadione

被引：9
|
作者：
Sidorova, YA [1 ]
Grishanova, AY [1 ]
Lyakhovich, VV [1 ]
机构：
[1] Russian Acad Med Sci, Inst Mol Biol & Biophys, Siberian Div, Novosibirsk 630090, Russia
来源：
TOXICOLOGY LETTERS | 2005年 / 155卷 / 02期
基金：
俄罗斯基础研究基金会;
关键词：
menadione; CYP1A1; CYP1A2; induction in vivo;
D O I：
10.1016/j.toxlet.2004.10.001
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
The effects of menadione on activities and expression of cytochrome P45.0 (CYP) 1A subfamily (CYP1A) isozymes in rat hepatic tissue were examined. When rats were treated orally with 15 mg/kg menadione for 4 days, the elevation of hepatic CYP1A1/1A2 specific activities in microsomal preparations was detected with approximately 5.4- and 2.5-fold increase over control values for ethoxyresorufin-O-deethylase (EROD, CYP1A1) and methoxyresorufin-O-demethylase (MROD, CYP1A2) activities, respectively. CYP1A1 and CYP1A2 mRNA levels in the liver of menadione-treated rats were approximately 11.8- and 1.8-fold higher than in controls, respectively, whereas the expression of the CYP1A regulatory proteins aryl hydrocarbonreceptor (AhR) and AhR nuclear translocator (Arnt) was not changed at the mRNA level. The result of this study demonstrates that menadione induces CYP1A1/1A2 expression in vivo through either transcriptional activation and/or mRNA stabilization. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码：253 / 258
页数：6
相关论文
共 50 条
  • [1] SYNERGISTIC INDUCTION OF RAT MICROSOMAL CYP1A1 AND CYP1A2 BY ACETONE IN COMBINATION WITH PYRIDINE
    IBA, MM
    BENNETT, S
    STORCH, A
    GHOSAL, A
    THOMAS, PE
    CANCER LETTERS, 1993, 74 (1-2) : 69 - 74
  • [2] INDUCTION OF CYP1A1 AND CYP1A2 AS ASSESSED BY ENZYMOLOGY AND RNA QUANTITATION
    DRAGNEV, K
    LUBET, RA
    NERURKAR, P
    FASEB JOURNAL, 1992, 6 (01): : A456 - A456
  • [3] Species differences in hepatocyte induction of CYP1A1 and CYP1A2 by omeprazole
    Shih, H
    Pickwell, GV
    Guenette, DK
    Bilir, B
    Quattrochi, LC
    HUMAN & EXPERIMENTAL TOXICOLOGY, 1999, 18 (02) : 95 - 105
  • [4] Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice
    Kapelyukh, Y.
    Henderson, C. J.
    Scheer, N.
    Rode, A.
    Wolf, C. R.
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (08) : 907 - 918
  • [5] Induction of CYP1A by benzo[k]fluoranthene in human hepatocytes:: CYP1A1 or CYP1A2?
    Liu, N
    Zhang, QY
    Vakharia, D
    Dunbar, D
    Kaminsky, LS
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 389 (01) : 130 - 134
  • [6] Persistent induction of CYP1A1 by 3-methylcholanthrene: Role of CYP1A2
    Moorthy, Bhagavatula
    Jiang, Weiwu
    Wang, Lihua
    Couroucli, Xanthi
    Chun, Chu
    TOXICOLOGY LETTERS, 2012, 211 : S54 - S54
  • [7] CYP1A1/CYP1A2 polymorphisms and colorectal cancer
    Ozhan, Gul
    Mutur, Mine
    TOXICOLOGY LETTERS, 2012, 211 : S69 - S69
  • [8] Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the Ahr-Null mouse
    Zaher, H
    Yang, TJ
    Gelboin, HV
    FernandezSalguero, P
    Gonzalez, FJ
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (02) : 235 - 238
  • [9] Induction of CYP1A1 and CYP1A2 expressions by prototypic and atypical inducers in the human lung
    Wei, C
    Caccavale, RJ
    Weyand, EH
    Chen, S
    Iba, MM
    CANCER LETTERS, 2002, 178 (01) : 25 - 36
  • [10] CYP1A2 is expressed along with CYP1A1 in the human lung
    Wei, C
    Cacavale, RJ
    Kehoe, JJ
    Thomas, PE
    Iba, MM
    CANCER LETTERS, 2001, 164 (01) : 25 - 32
12345